Bioceres Crop Solutions Corp(BIOX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 2 at 4:00 PM ET (Korea 11/3 06:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.76 | Insider Own | 18.15% | Shs Outstand | 62.0M | Perf Week | 9.21% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 51.8M | Perf Month | -35.14% |
| Enterprise Value | 0.27B | PEG | - | EPS next Q | - | Inst Own | 23.29% | Short Float | 1.65% | Perf Quarter | -41.38% |
| Income | -0.05B | P/S | 0.06 | EPS this Y | - | Inst Trans | -1.58% | Short Ratio | 2.75 | Perf Half Y | -50.36% |
| Sales | 0.25B | P/B | 9.6 | EPS next 5Y | - | ROA | -8.33% | Short Interest | 0.85M | Perf YTD | -83.08% |
| Book/sh | 0.02 | P/C | 1.15 | EPS past 3/5Y | - -47.12% | ROE | -39.19% | 52W High | -89.44% ($2.10) | Perf Year | -89.08% |
| Cash/sh | 0.19 | P/FCF | 0.2 | Sales past 3/5Y | -17.23% 2.85% | ROIC | -60.59% | 52W Low | 16.68% ($0.19) | Perf 3Y | -97.91% |
| Dividend Est. | - | EV/EBITDA | 18.42 | EPS Y/Y TTM | 14.85% | Gross Margin | 32.94% | Volatility(W/M) | 18.71% 13.24% | Perf 5Y | -98.26% |
| Dividend TTM | - | EV/Sales | 1.11 | Sales Y/Y TTM | -26.1% | Oper. Margin | -1.26% | ATR (14) | 0.03 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.61 | EPS Q/Q | 51.07% | Profit Margin | -19.59% | RSI (14) | 33.77 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.8 | Sales Q/Q | -23.35% | SMA20 | -18.59% ($0.27) | Beta | 0.53 | Target Price | $2 |
| Payout | - | Debt/Eq | 174.39 | Earnings | 2026/9/14 | SMA50 | -35.85% ($0.34) | Rel Volume | 1.39 | Prev Close | $0.21 |
| Employees | 562 | LT Debt/Eq | 54.58 | EPS/Sales Surpr. | - | SMA200 | -52.25% ($0.46) | Avg Volume(3M) | 0.31M | Price | $0.22 |
| IPO | 2018/3/22 | Option/Short | Yes/Yes | Trades | 452 | Volume | 432,154 | Change | 6.59% |
🌾 Bioceres Crop Solutions () is an Argentina-based seed and biological agricultural inputs company that offers drought-tolerant GM soybeans called 'HB4', as well as inoculants, fertilizers, and biocontrol products. Recently, the company has been pushing to transition to a more capital-efficient business model.
Over the past 1 year, on the lower side
90% below its 1-year high.
Traded more than usual. That is 139% of its average volume.
BIOX has weak earnings and a weak balance sheet
Of every $100 in sales, $1.26 is lost.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $6. Peers typically go for $111.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -98.3%. The S&P 500 did +63% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 23.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #11 of 13 in the industry
Based on market cap of $14M.
IPI#9 Intrepid Potash Inc $417M PER 31.3 
AVD#10 American Vanguard Corp $32M PER - BIOX#11 Bioceres Crop Solutions Corp $14M PER - 
SEED#12 Origin Agritech Ltd $11M PER - 
NXTS#13 Nexentis Technologies Inc $2M PER - 
FAQ
What kind of company is BIOX?
BIOX belongs to the Basic Materials sector and operates in the Agricultural Inputs industry.
What is the market cap of BIOX?
The market cap of BIOX is approximately $14M, ranking 5,319 within its sector.
What is the 52-week high and low for BIOX?
BIOX has recorded a 52-week high of $2.10 and a low of $0.19.
